HRP931360B1 - Transdermal therapeutic system containing the active t estradiol - Google Patents

Transdermal therapeutic system containing the active t estradiol

Info

Publication number
HRP931360B1
HRP931360B1 HRP4237453.7A HRP931360A HRP931360B1 HR P931360 B1 HRP931360 B1 HR P931360B1 HR P931360 A HRP931360 A HR P931360A HR P931360 B1 HRP931360 B1 HR P931360B1
Authority
HR
Croatia
Prior art keywords
estradiol
adhesive layer
therapeutic system
transdermal therapeutic
matrix layers
Prior art date
Application number
HRP4237453.7A
Other languages
English (en)
Inventor
Robert Peter Klein
Original Assignee
Robert Peter Klein
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6472230&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP931360(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Robert Peter Klein filed Critical Robert Peter Klein
Publication of HRP931360A2 publication Critical patent/HRP931360A2/hr
Publication of HRP931360B1 publication Critical patent/HRP931360B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
HRP4237453.7A 1992-11-06 1993-11-04 Transdermal therapeutic system containing the active t estradiol HRP931360B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4237453A DE4237453C1 (pl) 1992-11-06 1992-11-06

Publications (2)

Publication Number Publication Date
HRP931360A2 HRP931360A2 (en) 1995-02-28
HRP931360B1 true HRP931360B1 (en) 1999-12-31

Family

ID=6472230

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP4237453.7A HRP931360B1 (en) 1992-11-06 1993-11-04 Transdermal therapeutic system containing the active t estradiol

Country Status (24)

Country Link
US (1) US5912008A (pl)
EP (1) EP0716599B1 (pl)
JP (1) JP3237016B2 (pl)
KR (1) KR100306946B1 (pl)
AT (1) ATE164516T1 (pl)
AU (1) AU678408B2 (pl)
CA (1) CA2147172C (pl)
CZ (1) CZ286907B6 (pl)
DE (2) DE4237453C1 (pl)
DK (1) DK0716599T3 (pl)
ES (1) ES2117152T3 (pl)
FI (1) FI113339B (pl)
HR (1) HRP931360B1 (pl)
HU (1) HU221847B1 (pl)
IL (1) IL107395A (pl)
MY (1) MY118171A (pl)
NO (1) NO311783B1 (pl)
NZ (1) NZ257137A (pl)
PL (1) PL174604B1 (pl)
SI (1) SI9300581A (pl)
SK (1) SK279911B6 (pl)
WO (1) WO1994010984A1 (pl)
YU (1) YU69693A (pl)
ZA (1) ZA938257B (pl)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990009784A1 (en) * 1989-02-28 1990-09-07 Teijin Limited Poultice and preparation thereof
DK0695177T3 (da) * 1993-04-20 1998-09-28 Hexal Ag Plaster indeholdende aktivt stof
DE4429664C2 (de) * 1994-08-20 1997-09-11 Lohmann Therapie Syst Lts Estradiol-TTS mit wasserbindenden Zusätzen und Verfahren zu seiner Herstellung
US5906830A (en) * 1995-09-08 1999-05-25 Cygnus, Inc. Supersaturated transdermal drug delivery systems, and methods for manufacturing the same
DE19600347A1 (de) * 1996-01-08 1997-07-10 Lohmann Therapie Syst Lts Hauthaftende pharmazeutische Zubereitung, insbesondere TTS zur Abgabe von 17-beta-Estradiol an den menschlichen Organismus
DE19701949A1 (de) * 1997-01-13 1998-07-16 Jenapharm Gmbh Transdermales therapeutisches System
US5968547A (en) 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
DE19827732A1 (de) * 1998-06-22 1999-12-23 Rottapharm Bv Transdermales System vom Matrix-Typ zur Abgabe von Wirkstoffen mit einer hohen Abgaberate von Steroid-Hormonen und die Verwendung eines derartigen Systems zur Hormonersatztherapie
JP4399044B2 (ja) * 1998-10-14 2010-01-13 久光製薬株式会社 吸収促進剤及び該吸収促進剤を有してなる経皮吸収製剤
US6631186B1 (en) * 1999-04-09 2003-10-07 Sbc Technology Resources, Inc. System and method for implementing and accessing call forwarding services
DE19925613A1 (de) * 1999-06-04 2000-12-07 Lohmann Therapie Syst Lts Verbundlaminat und Verfahren zu seiner Herstellung
ITRM20060440A1 (it) * 2006-08-10 2008-02-11 Carmine Antropoli Uso della nifedipina per il trattamento antirughe
US20100087768A1 (en) * 2008-10-02 2010-04-08 Forlano Paula Transdermal drug delivery system for liquid active ingredient
DE102010026903A1 (de) 2010-07-12 2012-01-12 Amw Gmbh Transdermales therapeutisches System mit Avocadoöl oder Palmöl als Hilfsstoff
WO2013006608A1 (en) 2011-07-05 2013-01-10 Novan, Inc. Topical compositions
WO2013006613A1 (en) 2011-07-05 2013-01-10 Novan, Inc. Methods of manufacturing topical compositions and apparatus for same
DE102012000369A1 (de) 2012-01-11 2013-07-11 Alfred E. Tiefenbacher (Gmbh & Co. Kg) Transdermales therapeutisches System mit Cholinesterase-Hemmer
US9855211B2 (en) 2013-02-28 2018-01-02 Novan, Inc. Topical compositions and methods of using the same
US10322082B2 (en) 2014-07-11 2019-06-18 Novan, Inc. Topical antiviral compositions and methods of using the same
KR102495101B1 (ko) 2014-07-11 2023-02-02 노반, 인크. 국소 항바이러스 조성물 및 그의 사용 방법
BR112018070578A2 (pt) 2016-04-13 2019-02-12 Novan, Inc. composições, sistemas, kits, e métodos para tratar uma infecção
DE102017127433A1 (de) * 2017-11-21 2019-05-23 Lts Lohmann Therapie-Systeme Ag TTS auf Basis von klebenden Weichmacher-Polymer-Matrices

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR527450A (fr) * 1919-12-04 1921-10-25 Gilbert Mahaut Système et dispositif pour la combustion des huiles lourdes dans les foyers industriels et autres
US4435180A (en) * 1982-05-25 1984-03-06 Alza Corporation Elastomeric active agent delivery system and method of use
GB2138286B (en) * 1983-04-19 1986-10-08 Dr Christopher Harry Mortimer Pharmaceutical composition for the treatment of hair loss
EP0186019B1 (de) * 1984-12-22 1993-10-06 Schwarz Pharma Ag Wirkstoffpflaster
US5145682A (en) * 1986-05-30 1992-09-08 Rutgers, The State University Of New Jersey Transdermal absorption dosage unit for postmenopausal syndrome treatment and process for administration
US5023084A (en) * 1986-12-29 1991-06-11 Rutgers, The State University Of New Jersey Transdermal estrogen/progestin dosage unit, system and process
FR2612785A1 (fr) * 1987-03-25 1988-09-30 Lhd Lab Hygiene Dietetique Dispositif auto-adhesif d'administration d'un principe actif par voie percutanee
US4863738A (en) * 1987-11-23 1989-09-05 Alza Corporation Skin permeation enhancer compositions using glycerol monooleate
US4994267A (en) * 1988-03-04 1991-02-19 Noven Pharmaceuticals, Inc. Transdermal acrylic multipolymer drug delivery system
WO1990009784A1 (en) * 1989-02-28 1990-09-07 Teijin Limited Poultice and preparation thereof
DE3933460A1 (de) * 1989-10-06 1991-04-18 Lohmann Therapie Syst Lts Oestrogenhaltiges wirkstoffpflaster
WO1991005529A1 (en) * 1989-10-13 1991-05-02 Watson Laboratories, Inc. Drug delivery systems and matrix therefor
AR246186A1 (es) * 1989-11-17 1994-07-29 Beta Pharm Co Procedimiento para fabricar un dispositivo para administrar estradiol por via transdermica.
DE4002281A1 (de) * 1990-01-26 1991-08-01 Lohmann Therapie Syst Lts Transdermales therapeutisches system mit dem wirkstoff tulobuterol
US5248676A (en) * 1990-05-17 1993-09-28 Hisamitsu Pharmaceutical Co., Inc. Estradiol percutaneous administration preparations

Also Published As

Publication number Publication date
SI9300581A (en) 1994-06-30
CZ286907B6 (en) 2000-08-16
SK279911B6 (sk) 1999-05-07
JPH08502987A (ja) 1996-04-02
IL107395A (en) 1997-08-14
PL174604B1 (pl) 1998-08-31
JP3237016B2 (ja) 2001-12-10
WO1994010984A1 (de) 1994-05-26
NO951765L (no) 1995-05-05
ATE164516T1 (de) 1998-04-15
HU221847B1 (hu) 2003-02-28
FI113339B (fi) 2004-04-15
CA2147172A1 (en) 1994-05-26
EP0716599A1 (de) 1996-06-19
SK58095A3 (en) 1995-11-08
HRP931360A2 (en) 1995-02-28
DK0716599T3 (da) 1999-01-11
FI952115A (fi) 1995-05-03
NO311783B1 (no) 2002-01-28
DE59308360D1 (de) 1998-05-07
US5912008A (en) 1999-06-15
EP0716599B1 (de) 1998-04-01
PL308532A1 (en) 1995-08-21
CA2147172C (en) 2003-12-23
MY118171A (en) 2004-09-30
CZ116295A3 (en) 1995-12-13
FI952115A0 (fi) 1995-05-03
IL107395A0 (en) 1994-01-25
YU69693A (sh) 1997-07-31
HU9501318D0 (en) 1995-06-28
HUT71681A (en) 1996-01-29
ZA938257B (en) 1994-06-08
ES2117152T3 (es) 1998-08-01
KR100306946B1 (ko) 2002-04-24
KR950703940A (ko) 1995-11-17
NO951765D0 (no) 1995-05-05
DE4237453C1 (pl) 1993-08-19
AU678408B2 (en) 1997-05-29
AU5338694A (en) 1994-06-08
NZ257137A (en) 1996-09-25

Similar Documents

Publication Publication Date Title
HRP931360B1 (en) Transdermal therapeutic system containing the active t estradiol
ATE108680T1 (de) Therapeutisches system zur verzögerten und gesteuerten transdermalen oder transmucosalen verabreichung von wirkstoffen (ii).
MY111126A (en) Transdermal therapeutic system comprising the active substance acetylsalicylic acid.
FI950165A (fi) Ihon läpäisevä terapeuttinen järjestelmä, jossa vaikuttavana aineena on 17-beta-estradioli (vedetön)
IL125160A0 (en) A transdermal therapeutic composition a process for its preparation and use thereof
MX9804617A (es) Preparacion farmaceutica estabilizada en la superficie para aplicarse sobre la piel.

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20121024

Year of fee payment: 20

PB20 Patent expired after termination of 20 years

Effective date: 20131105